openPR Logo
Press release

Thyroid Gland Disorders Treatment Market Research Report Forecast to 2023

09-15-2017 09:10 AM CET | Health & Medicine

Press release from: Transparency Market Research

Thyroid Gland Disorders Treatment Market

Thyroid Gland Disorders Treatment Market

As per the revenue, market for thyroid gland disorder is foreseen to grow at a strong CAGR of 3.1% since 2015 to 2023. By the end of 2016, the revenue was expected to be evaluated worth US$1.099 n, which was further anticipated to grow with worth US$2.41 n y the end of 2023. According to the geographical regional, Asia-Pacific appears to be a promising region. Whereas, North American region is the dominant one with the expected revenue of US$1.1 bn by the end of forecast period. This figure is expected to contribute to the major section of the overall revenue generated in the global market. On the basis of types, the hypothyroidism segment rules among the rest of them. This segment is anticipated to be dominant for next four years.

According to the report, the number of patients suffering from hypothyroidism is more than those suffering hyperthyroidism. This drives the market demand for hypothyroid gland drugs. There has been a noticeable rise in the older section of the society illness that in turn gives rise to diseases such as chronic thyroid gland disorder. Population suffering from other illness such as obesity and other cardiovascular diseases are more prone to thyroid gland disorders, which is another driving force for the growth in the market. Moreover, due to people suffering from iodine deficiency, also makes them more prone to the disease related to thyroid gland. The deficiency is usually seen in the expecting women and young children. As per the studies, more than two billion people are suffering from insufficiency of iodine in their body. Sub-Saharan Africa and South Asia are the regions which are majorly affected by the deficiency, which has an important role in balancing the hormones in thyroid gland.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3113

The growth in demand for the solution for thyroid gland disorder, fuels the development of thyroid therapeutics in developing and developed economies for example, China, India, Africa, and Middle East. One of the critical factors that could affect the growth of thyroid gland disorder market is increase in the number of generic medicines that is due to the expiration of the patented drugs all together. Moreover, these generic medicines are combined with some alternative drugs as well, preferred majorly in Eastern market.

Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/3113

Abbvie, one of the leading giants in the industry finds, creates, manufacturers, and offers pharmaceutical products. Its major concentration regions are neurological disorders, chronic autoimmune system diseases oncology, and virology including hepatitis C (HCV) and human immunodeficiency infection (HIV), metabolic ailments including thyroid sickness and complexities related with cystic fibrosis, and also different genuine wellbeing conditions. The organization as of late propelled Good Morning Hypothyroidism (GMH), a comprehensive program to underline on dealing with the long lasting state of hypothyroidism every day.

Global Thyroid Gland Disorders Treatment Market Report is available @ US$ 5795: http://www.transparencymarketresearch.com/checkout.php?rep_id=3113<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Gland Disorders Treatment Market Research Report Forecast to 2023 here

News-ID: 718872 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Thyroid

Thyroid Cancer Treatment Market Increasing Ageing Population and Thyroid Cancer …
The thyroid cancer treatment market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of the increasing healthcare expenditure and the rising prevalence of thyroid cancer. As per The American Society of Clinical Oncology, in 2020, 44,280 number of adults in the United States is estimated to suffer from thyroid cancer. Such increasing prevalence of thyroid cancer is further expected to drive the
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
The number of patients suffering from thyroid gland disorders across the globe is increasing at a rapid rate. This direct increase in demand is expected to be a primary driver for the development of thyroid gland disorder treatments. The number of patients with thyroid gland disorder is increasing due to a growing population of the elderly, who are prone to thyroid disorders and similar illnesses. Additionally, a person suffering from